Pancreatology 2020 Jan 21
Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort study.
Bolm L, Ohrner K, Nappo G, Rückert F, Zimmermann C, Rau BM, Petrova E, Honselmann KC, Lapshyn H, Bausch D, Weitz J, Sandini M, Keck T, Zerbi A, Distler M, Wellner UF
The benefit of adjuvant therapy in ampullary cancer (AMPAC) patients following pancreatoduodenectomy (PD) is debated. The aim of this study was to det ...
Read More
Source: PubMed
Cancer Treat. Rev.
Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
Lamarca A, Edeline J, McNamara MG, Hubner RA, Nagino M, Bridgewater J, Primrose J, Valle JW
Biliary tract cancer, including cholangiocarcinoma (CCA) and gallbladder cancer (GBC) are rare tumours with a rising incidence. Prognosis is poor, sin ...
Read More
Source: PubMed
HBPD INT 2020 Jan 11
Survival improvement and prognostic factors in recent management of extrahepatic cholangiocarcinoma: A single-center study.
Choe JW, Kim HJ, Kim JS
Cholangiocarcinoma was considered as a dismal disease with very poor prognosis until recently. Cholangiocarcinoma is increasingly found due to increas ...
Read More
Source: PubMed
Curr. Med. Chem. 2020 Jan 22
Clinical and translational research challenges in biliary tract cancers.
Lamarca A, Frizziero M, McNamara MG, Valle JW
Biliary tract cancers (BTC) are rare malignancies with a poor prognosis. There are many challenges encountered in treating these patients in daily pra ...
Read More
Source: PubMed
ANZ J Surg 2020 Jan 13
Pancreatic resection in patients with synchronous extra-pancreatic malignancy: outcomes and complications.
Mehta S, Tan GI, Nahm CB, Chua TC, Pearson A, Gill AJ, Samra JS, Mittal A
Patients may present with a resectable pancreatic tumour in the context of a concurrent primary extra-pancreatic malignancy. These patients pose a dil ...
Read More
Source: PubMed
